| Current/Former smokers
n=49(69,0)
|
Nerver smokers
n=22(31,0)
|
p-value
|
Sex,male | 41(83,7) | 7(31,8) | <0,001* |
Age (years) | 70,4±7,5 | 75,9±5,9 | 0,004* |
Risk factors
Alpha-1 antitrypsin deficiency
Expousure to biomass smoke
Occupational exposure
History of pulmonary tuberculosis
Chronic asthma
|
1(2,0)
22(44,0)
36(73,5)
11(22,4)
2(4,1)
|
1(4,5)
14(63,6)
12(54,5)
10(45,5)
2(9,1)
|
0,527
0,088
0,115
0,050
0,583
|
Bronchiectasis
Emphysema
|
24(49,0)
34(69,4)
|
17(77,3)
6(27,3)
|
0,026*
0,001*
|
Post-bronchodilator FEV1(%)
Post-bronchodilator FEV1/FVC(%)
|
32,6±9,7
42,7±11,4
|
Δ
-7,0
-7,4
|
34,2±7,4
53,0±11,0
|
Δ
-13,2
0,6
|
0,556
0,007*
|
PaO2(mmHg)
PaCO2(mmHg)
|
68,9±10,4
52,2±12,0
|
9,3
-15,1
|
71,6±12,6
49,8±6,8
|
9,9
-27,3
|
0,376
0,416
|
Target HNIV objective,achieved | 20(40,8) | 14(63,6) | 0,075 |